Reviva Pharmaceuticals Holdings RVPH Balance Sheet (2018-2026)

OTC RVPH
$0.34 +0.00 (+0.00%)
At close: Nov 13, 2026 · 4:00 PM EST
Reported Financials

Reviva Pharmaceuticals Holdings Quarterly Balance Sheet

Periods 34 quarters
Latest Sep 2026

Reviva Pharmaceuticals Holdings reported total assets of $18.56M and total liabilities of $5.48M for the quarter ended Sep 2026, up 29.5% year over year. This balance sheet covers 34 quarters of results from May 2018 through Sep 2026, standardized by Business Quant from the company’s SEC filings.

Balance SheetBalance Sheet May2018 Aug2018 Nov2018 Feb2019 May2019 Aug2019 Nov2019 Feb2020 May2020 Aug2020 Nov2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026 Sep2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
29.69M23.42M19.42M23.19M18.52M11.26M11.15M4.97M23.37M11.97M6.18M5.56M13.48M5.29M10.36M13.18M14.44M22.19M19.89M17.46M
Short-term InvestmentsInvestments (Current)
4.93M4.19M12.20M3.86M9.02M11.92M13.23M
Cash & Current Investments
29.69M23.42M19.42M23.19M18.52M11.26M11.15M4.97M23.37M11.97M11.11M9.75M25.68M9.15M19.39M25.10M27.67M22.19M19.89M17.46M
Prepaid Assets
1.72M1.85M1.22M0.85M0.40M1.65M0.69M0.41M0.25M0.74M0.53M0.33M0.67M0.76M0.35M0.25M0.66M0.55M0.40M0.28M
Current Assets
23.70M7.23M6.81M14.68M6.26M10.82M13.51M15.10M23.56M21.14M18.56M
Non-Current Assets
Long-Term Investments
Other Non-Current Assets
0.82M0.82M0.82M0.82M0.82M0.82M0.82M
Non-Current Assets
0.82M0.82M0.82M0.82M0.82M0.82M0.82M
Assets
31.40M25.27M20.64M24.04M18.92M12.90M11.84M5.39M23.70M13.50M8.05M7.63M15.50M7.08M11.63M14.33M15.92M23.56M21.14M18.56M
Liabilities
Current Liabilities
Accounts Payables
0.51M1.43M2.55M2.35M3.52M2.86M2.65M5.28M3.85M5.72M4.69M8.78M6.28M4.72M4.97M5.43M3.01M2.09M2.46M2.48M
Notes Payables
0.67M0.22M0.22M0.33M0.21M0.08M0.46M0.22M0.11M0.41M0.23M0.14M0.04M
Payables
0.51M1.43M2.55M2.35M3.52M3.53M2.87M5.50M3.85M6.05M4.90M8.86M6.74M4.95M5.08M5.43M3.42M2.32M2.60M2.52M
Accumulated Expenses
1.84M2.20M1.92M1.23M5.58M3.03M6.34M7.53M11.97M6.85M7.30M7.36M6.72M
Other Accumulated Expenses
3.43M0.30M6.38M8.70M10.50M0.40M0.38M0.45M0.43M0.50M0.48M0.92M0.63M0.79M0.72M0.25M0.20M
Current Taxes
3.58M6.04M6.56M9.21M13.03M
Total Current Liabilities
2.34M3.62M4.48M6.38M9.96M10.73M12.64M17.32M17.18M14.49M13.94M17.53M14.60M11.51M12.08M9.74M7.28M6.12M5.93M5.48M
Non-Current Liabilities
Non-Current Debt
Convertible Debt
Non-Current Deferred Revenue
Preferred Stock Liabilities
Minority Interest
Other Non-Current Liabilities
0.37M0.28M0.11M0.11M0.57M0.56M1.01M0.87M0.81M0.35M0.15M0.08M0.09M0.03M0.02M0.04M
Total Non-Current Liabilities
2.34M3.62M4.48M6.38M9.96M10.73M12.64M17.32M17.18M14.49M13.94M17.53M14.60M11.51M12.08M9.74M7.28M
Total Liabilities
2.72M3.91M4.58M6.49M10.53M11.29M13.66M18.20M17.98M14.84M14.09M17.61M14.69M11.54M12.09M9.78M7.28M6.12M5.93M5.48M
Shareholder's Equity
Total Debt
0.67M0.22M0.22M0.33M0.21M0.08M0.46M0.22M0.11M0.41M0.23M0.14M0.04M
Common Equity
28.69M21.36M16.06M17.56M8.39M1.61M-1.82M-12.81M5.72M-1.35M-6.04M-9.98M0.81M-4.46M-0.46M4.55M8.65M17.44M15.21M13.08M
Liabilities and Shareholders Equity
31.40M25.27M20.64M24.04M18.92M12.90M11.84M5.39M23.70M13.50M8.05M7.63M15.50M7.08M11.63M14.33M15.92M23.56M21.14M18.56M
Retained Earnings
-66.83M-74.20M-79.54M-85.86M-95.09M-101.95M-113.65M-125.00M-134.35M-141.80M-149.65M-158.01M-164.27M-170.71M-176.80M-180.80M-184.14M-187.33M-189.80M-192.10M

Reviva Pharmaceuticals Holdings Balance Sheet API

Pull Reviva Pharmaceuticals Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RVPH&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY